<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>All Visualizations - Imugene (IMU.AX) Stock Analysis</title>
    <link rel="stylesheet" href="css/style.css">
    <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/font-awesome/6.0.0-beta3/css/all.min.css">
    <style>
        /* SWOT Analysis Component Styles */
        .swot-analysis-component {
            margin-bottom: 40px;
            font-family: Arial, sans-serif;
        }

        .swot-tabs {
            display: flex;
            margin-bottom: 20px;
            border-radius: 4px;
            overflow: hidden;
        }

        .swot-tab {
            padding: 12px 20px;
            background: #f5f5f5;
            border: 1px solid #ddd;
            cursor: pointer;
            font-weight: 600;
            transition: all 0.3s ease;
        }

        .swot-tab:hover {
            background: #e9e9e9;
        }

        .swot-tab.active {
            background: #3498db;
            color: white;
            border-color: #2980b9;
        }

        /* Quadrant View Styles */
        .swot-grid {
            display: grid;
            grid-template-columns: 1fr 1fr;
            gap: 20px;
            margin-bottom: 30px;
        }

        .swot-quadrant {
            padding: 20px;
            border-radius: 8px;
        }

        .strengths-quadrant {
            background-color: rgba(46, 204, 113, 0.1);
            border-left: 5px solid #2ecc71;
        }

        .weaknesses-quadrant {
            background-color: rgba(231, 76, 60, 0.1);
            border-left: 5px solid #e74c3c;
        }

        .opportunities-quadrant {
            background-color: rgba(52, 152, 219, 0.1);
            border-left: 5px solid #3498db;
        }

        .threats-quadrant {
            background-color: rgba(241, 196, 15, 0.1);
            border-left: 5px solid #f1c40f;
        }

        .swot-quadrant h3 {
            margin-top: 0;
            color: #2c3e50;
            font-size: 1.4rem;
            margin-bottom: 15px;
        }

        .swot-quadrant ul {
            margin: 0;
            padding-left: 20px;
        }

        .swot-quadrant li {
            margin-bottom: 12px;
            line-height: 1.5;
        }

        .swot-quadrant strong {
            display: block;
            margin-bottom: 5px;
        }

        /* View Styles */
        .swot-view {
            display: none;
        }

        .swot-view.active {
            display: block;
        }

        /* Radar Chart View Styles */
        .radar-chart-container {
            display: flex;
            flex-direction: column;
            align-items: center;
            margin-bottom: 30px;
        }

        .radar-chart {
            width: 100%;
            max-width: 600px;
            height: 400px;
            margin-bottom: 20px;
        }

        .chart-controls {
            display: flex;
            justify-content: center;
        }

        .chart-control {
            padding: 8px 15px;
            margin: 0 5px;
            background: #f5f5f5;
            border: 1px solid #ddd;
            border-radius: 4px;
            cursor: pointer;
        }

        .chart-control.active {
            background: #3498db;
            color: white;
            border-color: #2980b9;
        }

        /* Comparison Table Styles */
        .comparison-table-container {
            overflow-x: auto;
        }

        .comparison-table {
            width: 100%;
            border-collapse: collapse;
        }

        .comparison-table th, 
        .comparison-table td {
            padding: 12px 15px;
            text-align: left;
            border-bottom: 1px solid #ddd;
        }

        .comparison-table th {
            background-color: #f5f5f5;
            font-weight: 600;
        }

        .comparison-table tr:hover {
            background-color: #f9f9f9;
        }

        .highlight-positive {
            color: #27ae60;
            font-weight: 600;
        }

        .highlight-negative {
            color: #e74c3c;
            font-weight: 600;
        }

        /* Responsive Adjustments */
        @media (max-width: 768px) {
            .swot-grid {
                grid-template-columns: 1fr;
            }
            
            .swot-tabs {
                flex-wrap: wrap;
            }
            
            .swot-tab {
                flex: 1 0 50%;
                text-align: center;
                padding: 10px;
                font-size: 0.9rem;
            }
        }
    </style>
</head>
<body>
    <div class="sidebar">
        <div class="sidebar-title">
            Imugene Analysis
        </div>
        <ul class="sidebar-nav">
            <li>
                <a href="index.html">
                    <i class="fas fa-home"></i>
                    Overview
                </a>
            </li>
            <li>
                <a href="financial_analysis.html">
                    <i class="fas fa-chart-line"></i>
                    Financial Analysis
                </a>
            </li>
            <li>
                <a href="clinical_trials.html">
                    <i class="fas fa-flask"></i>
                    Clinical Trials
                </a>
            </li>
            <li>
                <a href="technical_analysis.html">
                    <i class="fas fa-chart-bar"></i>
                    Technical Analysis
                </a>
            </li>
            <li>
                <a href="short_selling.html">
                    <i class="fas fa-arrow-down"></i>
                    Short Selling
                </a>
            </li>
            <li>
                <a href="competitor_analysis.html">
                    <i class="fas fa-users"></i>
                    Competitor Analysis
                </a>
            </li>
            <li>
                <a href="investment_thesis.html">
                    <i class="fas fa-lightbulb"></i>
                    Investment Thesis
                </a>
            </li>
            <li>
                <a href="options_trading.html">
                    <i class="fas fa-exchange-alt"></i>
                    Options Trading
                </a>
            </li>
            <li>
                <a href="csl_case_study.html">
                    <i class="fas fa-building"></i>
                    CSL Case Study
                </a>
            </li>
            <li>
                <a href="catalyst_calendar.html">
                    <i class="fas fa-calendar-alt"></i>
                    Catalyst Calendar
                </a>
            </li>
            <li>
                <a href="visualizations.html">
                    <i class="fas fa-chart-pie"></i>
                    All Visualizations
                </a>
            </li>
        </ul>
    </div>
    <div class="main-content">
        <header>
            <h1>All Visualizations - Imugene (IMU.AX)</h1>
            <div class="header-buttons">
                <button class="btn btn-primary">
                    <i class="fas fa-share-alt"></i> Share
                </button>
                <button class="btn btn-success">
                    <i class="fas fa-file-export"></i> Export
                </button>
                <button class="btn btn-info">
                    <i class="fas fa-calendar-week"></i> This week
                </button>
            </div>
        </header>

        <section>
            <h2>SWOT Analysis</h2>
            <div class="swot-analysis-component">
                <p>This interactive SWOT analysis highlights Imugene's key strategic position in the biotech market:</p>
                
                <div class="swot-tabs">
                    <div class="swot-tab active" data-view="quadrant">Quadrant View</div>
                    <div class="swot-tab" data-view="radar">Radar Chart</div>
                    <div class="swot-tab" data-view="bar">Bar Chart</div>
                    <div class="swot-tab" data-view="comparison">Competitor Comparison</div>
                </div>
                
                <!-- Quadrant View -->
                <div class="swot-view quadrant-view active">
                    <div class="swot-grid">
                        <div class="swot-quadrant strengths-quadrant">
                            <h3>Strengths</h3>
                            <ul>
                                <li>
                                    <strong>Proprietary Immunotherapy Technology</strong>
                                    Targeting multiple cancer pathways simultaneously with unique mechanisms of action
                                </li>
                                <li>
                                    <strong>Strong Leadership Team</strong>
                                    Industry veterans with proven track record in biotech development and exits
                                </li>
                                <li>
                                    <strong>Diverse Pipeline</strong>
                                    Multiple drug candidates across different technology platforms
                                </li>
                                <li>
                                    <strong>Positive Early Clinical Data</strong>
                                    Encouraging efficacy and safety signals from lead candidates
                                </li>
                                <li>
                                    <strong>Substantial Cash Position</strong>
                                    $100M provides runway through multiple value-creating milestones
                                </li>
                                <li>
                                    <strong>Improving Sentiment</strong>
                                    Recent data and presentations have been well-received by market
                                </li>
                            </ul>
                        </div>
                        
                        <div class="swot-quadrant weaknesses-quadrant">
                            <h3>Weaknesses</h3>
                            <ul>
                                <li>
                                    <strong>Significant Cash Burn Rate</strong>
                                    $50M annually requires careful cash management
                                </li>
                                <li>
                                    <strong>History of Dilutive Capital Raises</strong>
                                    Previous financing rounds have diluted existing shareholders
                                </li>
                                <li>
                                    <strong>No Approved Products</strong>
                                    Lack of revenue streams creates dependency on capital markets
                                </li>
                                <li>
                                    <strong>Clinical Trial Dependency</strong>
                                    Future value heavily dependent on clinical trial outcomes
                                </li>
                                <li>
                                    <strong>Management Concerns</strong>
                                    Some investors have raised questions about financing practices
                                </li>
                                <li>
                                    <strong>Sector Valuation Compression</strong>
                                    Biotech sector experiencing general valuation pressure
                                </li>
                            </ul>
                        </div>
                        
                        <div class="swot-quadrant opportunities-quadrant">
                            <h3>Opportunities</h3>
                            <ul>
                                <li>
                                    <strong>Positive Clinical Trial Results</strong>
                                    Could drive significant revaluation
                                </li>
                                <li>
                                    <strong>Acquisition Interest</strong>
                                    Potential target for larger pharmaceutical companies
                                </li>
                                <li>
                                    <strong>Partnership Deals</strong>
                                    Could provide non-dilutive funding
                                </li>
                                <li>
                                    <strong>Multiple Catalysts</strong>
                                    Expected in next 12-24 months
                                </li>
                                <li>
                                    <strong>Increasing Interest in Immunotherapies</strong>
                                    Growing market for novel cancer treatments
                                </li>
                                <li>
                                    <strong>Expanded Indications</strong>
                                    Could open larger market opportunities
                                </li>
                            </ul>
                        </div>
                        
                        <div class="swot-quadrant threats-quadrant">
                            <h3>Threats</h3>
                            <ul>
                                <li>
                                    <strong>Market Skepticism</strong>
                                    About commercial viability of novel therapies
                                </li>
                                <li>
                                    <strong>Competitive Landscape</strong>
                                    Well-funded rivals pursuing similar approaches
                                </li>
                                <li>
                                    <strong>Clinical Trial Failures</strong>
                                    Could severely impact valuation
                                </li>
                                <li>
                                    <strong>Dilutive Financing</strong>
                                    Potential for further share dilution
                                </li>
                                <li>
                                    <strong>Regulatory Hurdles</strong>
                                    Approval delays could impact timeline
                                </li>
                                <li>
                                    <strong>Market Sentiment</strong>
                                    Toward small-cap biotech remains cautious
                                </li>
                            </ul>
                        </div>
                    </div>
                </div>
                
                <!-- Radar Chart View -->
                <div class="swot-view radar-view">
                    <div class="radar-chart-container">
                        <div class="radar-chart">
                            <p>Radar chart visualization would be implemented here using a charting library like Chart.js.</p>
                            <p>This would show the relative strengths of each SWOT category in a radar/spider chart format.</p>
                        </div>
                        <div class="chart-controls">
                            <div class="chart-control active" data-factor="overall">Overall</div>
                            <div class="chart-control" data-factor="technology">Technology</div>
                            <div class="chart-control" data-factor="financial">Financial</div>
                            <div class="chart-control" data-factor="market">Market</div>
                        </div>
                    </div>
                </div>
                
                <!-- Bar Chart View -->
                <div class="swot-view bar-view">
                    <div class="radar-chart-container">
                        <div class="radar-chart">
                            <p>Bar chart visualization would be implemented here using a charting library like Chart.js.</p>
                            <p>This would show the count and relative importance of items in each SWOT category.</p>
                        </div>
                        <div class="chart-controls">
                            <div class="chart-control active" data-factor="count">Count</div>
                            <div class="chart-control" data-factor="impact">Impact</div>
                            <div class="chart-control" data-factor="probability">Probability</div>
                            <div class="chart-control" data-factor="timeline">Timeline</div>
                        </div>
                    </div>
                </div>
                
                <!-- Competitor Comparison View -->
                <div class="swot-view comparison-view">
                    <div class="comparison-table-container">
                        <table class="comparison-table">
                            <thead>
                                <tr>
                                    <th>Factor</th>
                                    <th>Imugene</th>
                                    <th>Competitor A</th>
                                    <th>Competitor B</th>
                                    <th>Competitor C</th>
                                </tr>
                            </thead>
                            <tbody>
                                <tr>
                                    <td>Technology Platform</td>
                                    <td class="highlight-positive">Multiple platforms</td>
                                    <td>Single platform</td>
                                    <td>Dual platforms</td>
                                    <td>Single platform</td>
                                </tr>
                                <tr>
                                    <td>Cash Position</td>
                                    <td class="highlight-positive">$100M</td>
                                    <td>$45M</td>
                                    <td class="highlight-positive">$120M</td>
                                    <td>$30M</td>
                                </tr>
                                <tr>
                                    <td>Burn Rate</td>
                                    <td class="highlight-negative">$50M/year</td>
                                    <td>$20M/year</td>
                                    <td class="highlight-negative">$60M/year</td>
                                    <td>$15M/year</td>
                                </tr>
                                <tr>
                                    <td>Clinical Stage</td>
                                    <td>Phase 1/2</td>
                                    <td>Phase 1</td>
                                    <td class="highlight-positive">Phase 2/3</td>
                                    <td>Phase 1</td>
                                </tr>
                                <tr>
                                    <td>Market Cap</td>
                                    <td>$220M</td>
                                    <td>$150M</td>
                                    <td class="highlight-positive">$450M</td>
                                    <td>$100M</td>
                                </tr>
                                <tr>
                                    <td>Partnerships</td>
                                    <td>Limited</td>
                                    <td>None</td>
                                    <td class="highlight-positive">Multiple</td>
                                    <td>One major</td>
                                </tr>
                            </tbody>
                        </table>
                    </div>
                </div>
            </div>
            
            <div class="analysis-implications">
                <h3>Strategic Implications</h3>
                <p>Based on this SWOT analysis, several key strategic implications emerge for Imugene:</p>
                <ul>
                    <li><strong>Prioritize Azer-cel Development:</strong> As the most advanced and valuable asset, ensuring successful progression of Azer-cel through clinical trials should be the primary focus</li>
                    <li><strong>Pursue Partnership Opportunities:</strong> Actively seek pharmaceutical partnerships to provide validation and non-dilutive funding</li>
                    <li><strong>Optimize Cash Runway:</strong> Carefully manage burn rate to extend runway through key value-creating milestones</li>
                    <li><strong>Enhance Investor Communication:</strong> Improve transparency and frequency of updates to address market skepticism</li>
                </ul>
            </div>
        </section>

        <section>
            <h2>Financial Visualizations</h2>
            <div class="chart-container">
                <h3>Cash Flow Projection</h3>
                <p>This chart shows Imugene's projected cash position over time, including burn rate and potential financing events.</p>
                <img src="img/cash_flow_projection.png" alt="Cash Flow Projection">
            </div>
        </section>

        <section>
            <h2>Market Position</h2>
            <div class="chart-container">
                <h3>Market Cap Comparison</h3>
                <p>This chart compares Imugene's market capitalization with other Australian biotech companies (excluding CSL).</p>
                <img src="img/market_cap_comparison_ex_csl.png" alt="Market Cap Comparison">
            </div>
        </section>

        <section>
            <h2>Technical Analysis</h2>
            <div class="chart-container">
                <h3>Share Price with Moving Averages</h3>
                <p>This chart shows Imugene's share price with 20-day, 50-day, and 200-day simple moving averages.</p>
                <img src="img/price_with_ma.png" alt="Share Price with Moving Averages">
            </div>
            <div class="chart-container">
                <h3>Short Interest vs Price</h3>
                <p>This chart shows the relationship between short interest and share price over time.</p>
                <img src="img/short_interest_vs_price.png" alt="Short Interest vs Price">
            </div>
        </section>

        <section>
            <h2>Valuation Models</h2>
            <div class="chart-container">
                <h3>Share Price Scenarios</h3>
                <p>This chart shows potential share price outcomes under different clinical and market scenarios.</p>
                <img src="img/share_price_scenarios.png" alt="Share Price Scenarios">
            </div>
            <div class="chart-container">
                <h3>NPV Scenarios</h3>
                <p>This chart shows the net present value (NPV) of Imugene under different clinical success probability scenarios.</p>
                <img src="img/npv_scenarios.png" alt="NPV Scenarios">
            </div>
        </section>

        <section>
            <h2>Clinical Pipeline</h2>
            <div class="chart-container">
                <h3>Clinical Trial Timeline</h3>
                <p>This Gantt chart shows the timeline for Imugene's clinical trials across different drug candidates.</p>
                <img src="img/clinical_trial_gantt_chart.png" alt="Clinical Trial Timeline">
            </div>
            <div class="chart-container">
                <h3>Drug NPV Comparison</h3>
                <p>This chart compares the risk-adjusted NPV of each drug candidate in Imugene's pipeline.</p>
                <img src="img/drug_npv_comparison.png" alt="Drug NPV Comparison">
            </div>
        </section>

        <section>
            <h2>Other Visualizations</h2>
            <div class="chart-container">
                <h3>IP Valuation Scenarios</h3>
                <p>This chart shows the valuation of Imugene's intellectual property under different scenarios.</p>
                <img src="img/ip_valuation_scenarios.png" alt="IP Valuation Scenarios">
            </div>
            <div class="chart-container">
                <h3>Dilution Comparison</h3>
                <p>This chart compares the dilutive impact of different financing options.</p>
                <img src="img/dilution_comparison.png" alt="Dilution Comparison">
            </div>
        </section>

        <footer>
            <p>Imugene (IMU.AX) Investment Analysis - April 2025</p>
            <p><a href="https://github.com/Hodge2Franklin/Imugene" target="_blank">View on GitHub</a></p>
        </footer>
    </div>

    <script>
        // SWOT Analysis Component JavaScript
        document.addEventListener('DOMContentLoaded', function() {
            // Get all SWOT analysis components
            const swotComponents = document.querySelectorAll('.swot-analysis-component');
            
            swotComponents.forEach(component => {
                const tabs = component.querySelectorAll('.swot-tab');
                const views = component.querySelectorAll('.swot-view');
                
                // Tab switching functionality
                tabs.forEach(tab => {
                    tab.addEventListener('click', function() {
                        // Remove active class from all tabs and views
                        tabs.forEach(t => t.classList.remove('active'));
                        views.forEach(v => v.classList.remove('active'));
                        
                        // Add active class to clicked tab
                        this.classList.add('active');
                        
                        // Show corresponding view
                        const viewType = this.getAttribute('data-view');
                        component.querySelector(`.${viewType}-view`).classList.add('active');
                    });
                });
                
                // Chart controls functionality
                const chartControls = component.querySelectorAll('.chart-control');
                chartControls.forEach(control => {
                    control.addEventListener('click', function() {
                        chartControls.forEach(c => c.classList.remove('active'));
                        this.classList.add('active');
                        
                        // In a real implementation, this would update the chart data
                        // For now, we'll just simulate a change
                        const factor = this.getAttribute('data-factor');
                        console.log(`Changing chart to show ${factor}`);
                        
                        // Here you would update the chart based on the selected factor
                    });
                });
            });
            
            // Timeframe dropdown functionality
            const timeframeButton = document.querySelector('.btn-info');
            if (timeframeButton) {
                timeframeButton.addEventListener('click', function() {
                    // Create dropdown if it doesn't exist
                    let dropdown = document.querySelector('.timeframe-dropdown');
                    if (!dropdown) {
                        dropdown = document.createElement('div');
                        dropdown.className = 'timeframe-dropdown';
                        dropdown.style.position = 'absolute';
                        dropdown.style.backgroundColor = 'white';
                        dropdown.style.boxShadow = '0 2px 10px rgba(0,0,0,0.1)';
                        dropdown.style.borderRadius = '4px';
                        dropdown.style.zIndex = '1000';
                        dropdown.style.display = 'none';
                        
                        const options = ['This week', 'This month', '3 months', '6 months', '1 year', 'All time'];
                        options.forEach(option => {
                            const item = document.createElement('div');
                            item.textContent = option;
                            item.style.padding = '10px 15px';
                            item.style.cursor = 'pointer';
                            item.addEventListener('mouseover', function() {
                                this.style.backgroundColor = '#f5f5f5';
                            });
                            item.addEventListener('mouseout', function() {
                                this.style.backgroundColor = 'white';
                            });
                            item.addEventListener('click', function() {
                                timeframeButton.textContent = option;
                                dropdown.style.display = 'none';
                                
                                // Show notification
                                const notification = document.createElement('div');
                                notification.textContent = `Timeframe changed to ${option}`;
                                notification.style.position = 'fixed';
                                notification.style.top = '20px';
                                notification.style.right = '20px';
                                notification.style.backgroundColor = '#2c3e50';
                                notification.style.color = 'white';
                                notification.style.padding = '10px 20px';
                                notification.style.borderRadius = '4px';
                                notification.style.zIndex = '2000';
                                document.body.appendChild(notification);
                                
                                setTimeout(() => {
                                    notification.style.opacity = '0';
                                    notification.style.transition = 'opacity 0.5s ease';
                                    setTimeout(() => {
                                        document.body.removeChild(notification);
                                    }, 500);
                                }, 3000);
                            });
                            dropdown.appendChild(item);
                        });
                        
                        document.body.appendChild(dropdown);
                    }
                    
                    // Position dropdown
                    const rect = timeframeButton.getBoundingClientRect();
                    dropdown.style.top = `${rect.bottom + window.scrollY}px`;
                    dropdown.style.left = `${rect.left + window.scrollX}px`;
                    
                    // Toggle display
                    dropdown.style.display = dropdown.style.display === 'none' ? 'block' : 'none';
                    
                    // Close dropdown when clicking outside
                    const closeDropdown = function(e) {
                        if (!dropdown.contains(e.target) && e.target !== timeframeButton) {
                            dropdown.style.display = 'none';
                            document.removeEventListener('click', closeDropdown);
                        }
                    };
                    
                    document.addEventListener('click', closeDropdown);
                });
            }
            
            // Share button functionality
            const shareButton = document.querySelector('.btn-primary');
            if (shareButton) {
                shareButton.addEventListener('click', function() {
                    alert('Share functionality would be implemented here. This would allow sharing the analysis via email, social media, or generating a shareable link.');
                });
            }
            
            // Export button functionality
            const exportButton = document.querySelector('.btn-success');
            if (exportButton) {
                exportButton.addEventListener('click', function() {
                    alert('Export functionality would be implemented here. This would allow exporting the analysis as PDF, Excel, or other formats.');
                });
            }
        });
    </script>
</body>
</html>
